Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
11/30/1989 | WO1989011294A1 Antiviral or antibacterial compound and method of use |
11/30/1989 | WO1989011293A1 Wound healing |
11/30/1989 | WO1989011291A1 Novel antimicrobial peptide, compositions containing same and uses thereof |
11/30/1989 | WO1989011290A1 Amphiphilic peptides and use thereof |
11/30/1989 | WO1989011289A1 Peptides having t cell helper activity |
11/30/1989 | WO1989011288A1 Lung growth stimulatory and inhibitory factors for carcinoma tumor cells |
11/30/1989 | WO1989011287A1 Induction of tolerance to a foreign antigen |
11/30/1989 | WO1989011285A1 Diagnostics and therapy for rheumatoid arthritis |
11/30/1989 | WO1989011277A2 Porphyrin and phthalocyanine antiviral compositions |
11/30/1989 | WO1989011270A1 Liposomes coupled to hormones |
11/30/1989 | WO1989011226A1 METHOD FOR FRACTIONATING PROTEINS OF HUMAN MILK LEADING TO THE PRODUCTION PARTICULARLY OF LACTOFERRINE AND alpha-LACTALBUMINE, AND PRODUCTS OBTAINED |
11/30/1989 | EP0323462A4 Use of interleukin-1 to induce development of multipotent hemopoietic cell populations. |
11/30/1989 | EP0310639A4 Omega-3 fatty acids in traumatic injury treatment. |
11/29/1989 | EP0344068A1 N-polyosyl-polypeptides |
11/29/1989 | EP0344006A2 Peptides that block the binding of hiv-1 to th CD4 receptor protein |
11/29/1989 | EP0343950A2 Human receptor Fc(gamma)RIII |
11/29/1989 | EP0343911A2 Cycloalkyl-substituted glutaramide diuretic agents |
11/29/1989 | EP0343696A2 Zinc-associated somatotropins |
11/29/1989 | EP0343684A1 Interleukin-1 inhibitors |
11/29/1989 | EP0343671A2 Pharmaceutical composition for the treatment of skin wounds |
11/29/1989 | EP0343654A2 Diol-containing renin inhibitors |
11/29/1989 | EP0343577A2 Des-17-histidine calcitonin |
11/29/1989 | EP0343480A1 Use of interleukin-2 in the immunostimulation of weakened immune reaction |
11/29/1989 | EP0343460A2 P. falciparum CS-peptides as universal T-cell epitope |
11/29/1989 | EP0343406A2 Use of lyzozyme in the preparation of an agent for the treatment of the mucous membrane of the nose |
11/29/1989 | EP0343388A2 Expression of interferon-gamma in methylotrophic yeasts |
11/29/1989 | EP0343275A1 Process for the production of a high purity, virus-free antihaemophilic factor by means of chromatography |
11/29/1989 | EP0343258A1 Agent for prophylaxis and treatment of virally infected diseases |
11/29/1989 | EP0343248A1 Novel polypeptide and method for preparing the same |
11/29/1989 | EP0343231A1 PRODUCTION OF ANIMAL LYSOZYME c VIA SECRETION FROM PICHIA PASTORIS AND COMPOSITION THEREFOR |
11/29/1989 | CN1037519A Heterocyclic ketones |
11/28/1989 | US4883865 Hepatitis b virus, solvent extraction, polyoxyethylene glycol and dextran |
11/28/1989 | US4883863 Tripeptide derivatives and antiplasmin agents containing the same |
11/28/1989 | US4883861 Cysteine-rich peptides having gamma-glutamic acid and beta-alanine units, a process for their preparation and their use |
11/28/1989 | US4883802 Improving impaired brain function |
11/28/1989 | US4883790 Use of hydro-monobenzoporphyrins to mediate the destruction of unwanted cells or tissues by irradiation |
11/28/1989 | US4883784 Human complement factors and their therapeutic use |
11/28/1989 | US4883682 Process for the preparation of a sterilized casein-based liquid composition |
11/28/1989 | US4883661 Use of arginine as an lymphokine synergist |
11/28/1989 | US4883598 Process for isolating coagulation factors, and adsorbent material suitable therefor |
11/28/1989 | CA1263500A1 Gnrh antagonists ii |
11/28/1989 | CA1263499A1 Growth promotants for animals |
11/28/1989 | CA1263329A1 Biologically active substances obtained from bovine casein, process for their preparation and compounds containing the same |
11/28/1989 | CA1263306A1 Vaccine and serum for endotoxin associated disease and method of preparing same as well as to methods of immunization and treatment of such disease and to a detoxified endotoxin and bacterial mutant |
11/23/1989 | EP0343137A1 Fibronectin binding protein |
11/23/1989 | EP0343085A1 Pentapeptides and their use as antithrombotics |
11/23/1989 | EP0342962A2 Peptides having T cell helper activity |
11/23/1989 | EP0342620A1 Agent for prevention and remedy of injuries caused by ischemia |
11/23/1989 | EP0342541A2 Retroviral protease inhibitors |
11/23/1989 | EP0342486A1 Antibiotic |
11/23/1989 | EP0342416A2 Medicine |
11/23/1989 | EP0342325A2 Renin-inhibiting amino acid derivatives |
11/23/1989 | EP0342219A1 Protein homologue of human angiogenine |
11/23/1989 | EP0342206A1 Human interleukin-3 proteins |
11/23/1989 | DE3915317A1 Verwendung von gonadoliberinderivaten Use of gonadoliberinderivaten |
11/23/1989 | DE3816534A1 Process for the production of natural human interleukin-1 beta (IL-1 beta ) in cell culture |
11/23/1989 | DE3816298A1 Anabolic peptides |
11/22/1989 | CN1037360A Law molecular wieght derivatives of prourokinase, and pharmaceutical composition containing same |
11/22/1989 | CN1037349A Copolymers and superoxide dismutase modified with said copolymers |
11/21/1989 | US4882424 Activation antigen |
11/21/1989 | US4882422 Pulmonary surfactant proteins |
11/21/1989 | US4882421 Pharmaceutical for treating tumors and method for making it |
11/21/1989 | US4882419 Process for preparing antibiotic L 17392 (deglucoteicoplanin) |
11/21/1989 | US4882336 Administering ethyl apovincaminate |
11/21/1989 | US4882326 Piperidine compounds and pharmaceutical uses thereof |
11/21/1989 | US4882313 Carboxamide derivatives of glycopeptides |
11/21/1989 | US4882282 DNA sequences encoding bovine interleukin-2 |
11/21/1989 | US4882275 Method of purifying endothelial cell growth factors using immobilized heparin |
11/16/1989 | WO1989010967A1 Recombinant flagellin vaccines |
11/16/1989 | WO1989010964A1 Novel bovine granulocyte-macrophage colony stimulating factor variant |
11/16/1989 | WO1989010962A1 Process for producing a human neutrophil chemotactic factor polypeptide |
11/16/1989 | WO1989010961A1 Peptide analogs and their use as haptens to elicit catalytic antibodies |
11/16/1989 | WO1989010938A1 Protein micelles |
11/16/1989 | WO1989010937A1 Insulin analogues |
11/16/1989 | WO1989010936A1 Gene for encoding a human malaria vaccine antigen |
11/16/1989 | WO1989010935A1 Atrial peptide derivatives |
11/16/1989 | WO1989010934A1 Procalcitonin peptides |
11/16/1989 | WO1989010933A1 Polypeptide compounds having growth hormone releasing activity |
11/16/1989 | WO1989010932A1 Compositions and method for treating or preventing infections in animals |
11/16/1989 | WO1989010926A1 1,1-dioxo-cephem-4-carbothiolic acid derivatives |
11/16/1989 | WO1989010920A1 Renin inhibitory peptides containing a substituted phenoxyacetyle group |
11/16/1989 | WO1989010756A1 STABLE INTERFERON beta COMPOSITION |
11/16/1989 | WO1989010754A1 Therapeutic methods using catalytic antibodies |
11/16/1989 | WO1989010752A1 Retroviral protease inhibitors |
11/16/1989 | WO1989010751A1 Functionalized peptidyl aminodiols and -triols |
11/16/1989 | WO1989010735A1 Probursin |
11/16/1989 | WO1989009621A3 Compounds for diagnosis and/or therapy of tumours |
11/16/1989 | DE3915617A1 Compositions for topical use containing cyclosporins |
11/16/1989 | DE3910084A1 Polypeptide mit wachstumsfaktor-aktivitaet und nukleinsaeuresequenzen Polypeptides with growth factor activity and nucleic acid sequences of |
11/16/1989 | DE3814806A1 Method for the stabilisation of amino-acid infusion solutions |
11/15/1989 | EP0342173A2 Fibronectin binding protein as well as its preparation |
11/15/1989 | EP0342128A1 Papillomavirus probes (HPV49, HPV50, HPV54, HPV55), products genetically and immunologically related to this papillomavirus and in vitro methods for the diagnosis of papillomavirus infections and for the production of antibodies against these papillomaviruses |
11/15/1989 | EP0342015A2 Peptides, their use and pharmaceutical compositions containing them |
11/15/1989 | EP0341963A2 Parathyroid hormone antagonists |
11/15/1989 | EP0341962A2 Humoral hypercalcemic factor antagonists |
11/15/1989 | EP0341915A2 Anti-aggregatory peptides |
11/15/1989 | EP0341734A2 Proteins having anti-tumor activity |
11/15/1989 | EP0341684A2 Human monoclonal antibody, hybridoma producing the same and pharmaceutical |
11/15/1989 | EP0341661A2 Peptide-drug compositions containing alpha-aminoboronic acid derivatives |
11/15/1989 | EP0341624A2 Method of effecting immunosuppression |